Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “INOVIO”

75 pharma patents match "INOVIO" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 75
Index total 30,257
Page 1 / 4

Quick answer

This filtered view shows 75 pharmaceutical patents matching "INOVIO" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

75 results for “INOVIO” · 30,257 patents in full index Clear search

  1. US 12285473

    Cancer vaccines targeting MUC16 and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  2. US 12280108

    Vaccines having an antigen and interleukin-21 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  3. US 12251561

    Minimally invasive dermal electroporation device

    Inovio Pharmaceuticals, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  4. US 12240872

    Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

    Inovio Pharmaceuticals, Inc. · Granted Mar 4, 2025 · Expires Feb 27, 2045

    granted
  5. US 12161706

    Cancer vaccines targeting BORIS and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  6. US 12109258

    Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections

    Inovio Pharmaceuticals, Inc. · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted
  7. US 12064473

    Cancer vaccines targeting Survivin and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  8. US 12054537

    Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies

    Inovio Pharmaceuticals, Inc. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  9. US 12053619

    Intradermal jet injection electroporation

    Inovio Pharmaceuticals, Inc. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  10. US 12049479

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Inovio Pharmaceuticals, Inc. · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  11. US 11986517

    Cancer vaccines targeting mesothelin and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  12. US 11980659

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Inovio Pharmaceuticals, Inc. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  13. US 11981724

    DNA antibody constructs for use against middle east respiratory syndrome coronavirus

    Inovio Pharmaceuticals, Inc. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  14. US 11925685

    DNA antibody constructs encoding anti-ZIKV envelope antibodies

    Inovio Pharmaceuticals, Inc. · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  15. US 11896654

    DNA monoclonal antibodies targeting checkpoint molecules

    Inovio Pharmaceuticals, Inc. · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  16. US 11865166

    Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor

    Inovio Pharmaceuticals, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  17. US 11851477

    DNA monoclonal antibodies targeting influenza virus

    Inovio Pharmaceuticals, Inc. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  18. US 11845787

    DNA antibody constructs for use against HIV

    Inovio Pharmaceuticals, Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  19. US 11844830

    Vaccines for human papilloma virus and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  20. US 11801288

    Cancer vaccines and methods of treatment using the same

    Inovio Pharmaceuticals, Inc. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  21. US 11801298

    MERS-CoV vaccine

    Inovio Pharmaceuticals, Inc. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  22. US 11744885

    Vaccines for recurrent respiratory papillomatosis and methods of using the same

    Inovio Pharmaceuticals, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  23. US 11660335

    Vaccines against coronavirus and methods of use

    Inovio Pharmaceuticals, Inc. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  24. US 11638747

    WT1 vaccine

    Inovio Pharmaceuticals, Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted